Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exocyst complex component 4 (EXOC4) is a protein encoded by the *EXOC4* gene in humans and is a core subunit of the exocyst complex[1][2][5][7]. The exocyst is an evolutionarily conserved, hetero-octameric tethering complex involved in targeting exocytic vesicles to precise docking sites on the plasma membrane, and is required for functions such as membrane fusion, exocytosis, endocytosis, autophagy, cell polarization, and epithelial cell surface polarity[1][2][3][7]. EXOC4 and other exocyst subunits coordinate with the actin cytoskeleton and small GTPases to ensure fidelity of vesicular trafficking and membrane assembly[2][3][7]. This protein is not commonly considered a direct therapeutic target or receptor, but is crucial for cellular organization and transport processes. Mutations in EXOC4 have been associated with diseases such as Meckel syndrome type 1 and disorders of the peripheral nervous system, reflective of its key role in cellular architecture and trafficking[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exocyst complex component 4 (EXOC4).